According to clinical trials published in the New England Journal of Medicine, Zepbound shows slightly higher rates of GI effects at higher doses: nausea (31-33%), diarrhea (21-23%), and vomiting (12-20%)
Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist licensed in the UK for type 2 diabetes and, following a positive NICE technology appraisal (TA1026), recommended for weight management in eligible adults within specialist services
CoverWell: A Safety Net for Patients and Providers in Peptide/GLP-1 and Regenerative Therapies Modern regenerative medicinecovering GLP-1s, peptides, stem cells, and exosomes offers life-changing possibilities in weight loss, longevity, recovery, and performance optimization
1 Some have cited concern over confounding variables including the fact that patients with diabetes are at an increased risk of acute pancreatitis regardless of treatment choice
Always consult a doctor before starting any medicine
Why is muscle preservation important during weight loss
:max_bytes(150000):strip_icc():focal(745x118:747x120)/trish-webster-ozempic-death-110923-691e3adb3e524a0abaf476e7a6445a7c.jpg)
